Theoretical and Experimental Design of Atypical Kinase Inhibitors: Application to p38 MAP Kinase.
McClure, K.F., Abramov, Y.A., Laird, E.R., Barberia, J.T., Cai, W., Carty, T.J., Cortina, S.R., Danley, D.E., Dipesa, A.J., Donahue, K.M., Dombroski, M.A., Elliott, N.C., Gabel, C.A., Han, S., Hynes, T.R., Lemotte, P.K., Mansour, M.N., Marr, E.S., Letavic, M.A., Pandit, J., Ripin, D.B., Sweeney, F.J., Tan, D., Tao, Y.(2005) J Med Chem 48: 5728-5737
- PubMed: 16134941 
- DOI: 10.1021/jm050346q
- Primary Citation of Related Structures:  
1ZZL - PubMed Abstract: 
Mimics of the benzimidazolone nucleus found in inhibitors of p38 kinase are proposed, and their theoretical potential as bioisosteres is described. A set of calculated descriptors relevant to the anticipated binding interaction for the fragments 1-methyl-1H-benzotriazole 5, 3-methyl-benzo[d]isoxazole 3, and 3-methyl-[1,2,4]triazolo[4,3-a]pyridine 4, pyridine 1, and 1,3-dimethyl-1,3-dihydro-benzoimidazol-2-one 2 are reported ...